Limandri Barbara J
J Psychosoc Nurs Ment Health Serv. 2018 Jul 1;56(7):9-14. doi: 10.3928/02793695-20180619-03.
Acute and chronic insomnia are common and difficult clinical problems that contribute to and are consequences of other mental and physical health problems. It is tempting to treat insomnia with medications for rapid relief; however, these medications have significant side effects that add health burden and may cause tolerance and dependency. First-line treatment for insomnia is cognitive-behavioral therapy for insomnia (CBT-I); however, this is less frequently prescribed than benzodiazepine and non-benzodiazepine sedative hypnotic agents. Prudent primary care and mental health clinicians should screen for insomnia using valid and reliable tools when clients report sleep difficulties. When screening is positive, further assessment with a sleep diary is warranted. The primary treatment for insomnia is CBT-I, and pharmacological treatment may provide temporary support for no more than 2 to 4 weeks. Non-benzodiazepine hypnotic agents, histamine blocking medications, dual orexin receptor antagonists, and over-the-counter herbal supplements may serve as adjuncts. [Journal of Psychosocial Nursing and Mental Health Services, 56(7), 9-14.].
急性和慢性失眠是常见且棘手的临床问题,它们既是其他身心健康问题的成因,也是这些问题的后果。人们往往倾向于使用药物治疗失眠以迅速缓解症状;然而,这些药物具有显著的副作用,会增加健康负担,还可能导致耐受性和依赖性。失眠的一线治疗方法是失眠认知行为疗法(CBT-I);然而,与苯二氮䓬类和非苯二氮䓬类镇静催眠药相比,这种疗法的处方频率较低。当患者报告有睡眠困难时,谨慎的初级保健和心理健康临床医生应使用有效且可靠的工具对失眠进行筛查。筛查结果呈阳性时,有必要通过睡眠日记进行进一步评估。失眠的主要治疗方法是CBT-I,药物治疗可提供不超过2至4周的临时支持。非苯二氮䓬类催眠药、组胺阻断药物、双食欲素受体拮抗剂和非处方草药补充剂可作为辅助治疗。[《心理社会护理与心理健康服务杂志》,56(7),9 - 14。]